Immunolocalization of thrombospondin in the human and sand rat intervertebral disc

Spine

Volumn 31, Issue 22, 2006, Pages 2556-2561

  Gruber, Helen E ^a   Ingram, Jane A ^a   Hanley Jr , Edward N ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Disc; Matricellular protein; Thrombospondin; Vascularity

Indexed keywords

THROMBOSPONDIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; INTERVERTEBRAL DISK; MALE; NONHUMAN; PRIORITY JOURNAL; PSAMMOMYS OBESUS; RAT;

ADOLESCENT; ADULT; AGED; ANIMALS; CELLS, CULTURED; FEMALE; GERBILLINAE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPECIES SPECIFICITY; THROMBOSPONDINS;

EID: 33750365739     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000241117.31510.e3     Document Type: Article

References (45)

1. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002;14:608-16.
2. Gruber HE, Ingram JA, Hanley EN Jr. Tenascin in the human intervertebral disc: alterations with aging and disc degeneration. Biotech Histochem 2002;77:37-41.
3. Gruber HE, Ingram JA, Leslie K, et al. Cellular, but not matrix, immunolocalization of SPARC in the human intervertebral disc: decreasing localization with aging and disc degeneration. Spine 2004;29:2223-8.
4. Gruber HE, Sage EH, Norton HJ, et al. Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse. J Histochem Cytochem 2005;53:1131-8.
5. Agah A, Kyriakides TR, Bornstein P. Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2-null fibroblasts and mice. Am J Pathol 2005;167:81-8.
6. Bornstein P, Armstrong LC, Hankenson KD, et al. Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 2000;19:557-68.
7. Dejong V, Degeorges A, Filleur S, et al. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun. Oncogene 1999;18:3143-51.
8. Kyriakides TR, Zhu Y-H, Smith LT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 1998;140:419-30.
9. Simantov R, Febbraio M, Silverstein RL. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Matrix Biol 2005;24:27-34.
10. Yang Z, Kyriakides TR, Bornstein P. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproetinase-2. Mol Biol Cell 2000;11:3353-64.
11. Breitkopf K, Sawitza I, Westhoff JH, et al. Thrombospondin 1 acts as a strong promoter of transforming growth factor β effects via two distinct mechanisms in hepatic stellate cells. Gut 2005;54:673-81.
12. Thompson JP, Pearce RH, Schechter MT, et al. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 1990;15:411-5.
13. Gruber HE, Fisher EC Jr, Desai B, et al. Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-β1. Exp Cell Res 1997;235:13-21.
14. Gruber HE, Stasky AA, Hanley EN Jr. Characterization and phenotypic stability of human disc cells in vitro. Matrix Biol 1997;16:285-8.
15. Gruber HE, Ingram JA, Leslie K, et al. Cell shape and gene expression in human intervertebral disc cells: in vitro tissue engineering studies. Biotech Histochem 2003;78:109-17.
16. Gruber HE, Leslie K, Ingram J, et al. Cell-based tissue engineering for the intervertebral disc: in vitro studies of human disc cell gene expression and matrix production within selected cell carriers. Spine J 2004;4:44-55.
17. Gruber HE, Johnson T, Norton HJ, et al. The sand rat model for disc degeneration. Radiologic characterization of age-related changes: cross-sectional and prospective analyses. Spine 2002;27:230-4.
18. Gruber HE, Johnson TL, Leslie K, et al. Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine 2002;27:1626-33.
19. Armstrong LC, Kyriakides TR, Bornstein P. The role of thrombospondins 1 and 2 in vascular development. In: Weir EK, Archer SL, Reeves JT, eds. The Fetal and Neonatal Pulmonary Circulations [AHA Monograph Series], 1st ed. Armonk, NY: Futura, 1998:87-103.
20. Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol 2000;19:597-614.
21. Dawson DW, Bouck NP. Thrombospondin as an inhibitor of angiogenesis. In: Teicher BA, ed. Antiangiogenic Agents in Cancer Therapy. Totowa, NJ: Humana Press, 1999:185-203.
22. Panetti TS, Chen H, Misenheimer TM, et al. Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 1997;129:208-16.
23. Volpert OV, Tolsma SS, Pellerin S, et al. Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 1995;217:326-32.
24. Crock HV, Goldwasser M, Yoshizawa H. Vascular anatomy related to the intervertebral disc. In: Ghosh P, ed. The Biology of the Intervertebral Disc, vol. I. Boca Raton, FL: CRC Press, 1988:109-33.
25. Eyre D, Benya P, Buckwalter J, et al. Basic science perspectives. In: Frymoyer JW, Gordon SL, eds. New Perspectives on Low Back Pain. Park Ridge, IL: American Academy of Orthopaedic Surgeons, 1988:147-214.
26. Fraser RD, Bleasel JF, Moskowitz RW. Spinal degeneration: pathogenesis and medical management. In: Ducker TB, Hadler NM, Kostuik JP, et al, eds. The Adult Spine: Principles and Practices, 2d ed. Philadelphia: Lippincott-Raven, 1997:735-59.
27. Maroudas A. Nutrition and metabolism of the intervertebral disc. In: Ghosh P, ed. The Biology of the Intervertebral Disc, vol II. Boca Raton, FL: CRC Press, 1988:1-37.
28. Maroudas A, Stockwell RA, Nachemson A, et al. Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. J Anat 1975;120:113-30.
29. Gruber HE, Ashraf N, Kilburn J, et al. Vertebral endplate architecture and vascularization: application of micro-CT imaging, a vascular traced, and immunocytochemistry in analysis of disc degeneration in the aging sand rat. Spine 2005;30:2593-600.
30. Kauppila LI. Ingrowth of blood vessels in disc degeneration: angiographic and histological studies of cadaveric spines. J Bone Joint Surg Am 1995;77:26-31.
31. Pai RR, D'sa B, Raghuveer CV, et al. Neovascularization of nucleus pulposus: a diagnostic feature of intervertebral disc prolapse. Spine 1999;24:739-41.
32. Virri J, Gronblad M, Savikko J, et al. Prevalence, morphology, and topography of blood vessels in herniated disc tissue: a comparative immunocytochemical study. Spine 1996;21:1856-63.
33. Yasuma T, Arai K, Yamauchi Y. The histology of lumbar intervertebral disc herniation: the significance of small blood vessels in the extruded tissue. Spine 1993;18:1761-5.
34. Tolonen J, Gronblad M, Virri J, et al. Basic fibroblast growth factor immunoreactivity in blood vessels and cells of disc herniations. Spine 1995;20:271-6.
35. Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res 2005;65:3967-79.
36. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim et Biophys 2004;1654:13-22.
37. Folkman J. Endogenous angiogenesis inhibitors. APMIS 112:496-507.
38. Nakamura T, Matsumoto K. Angiogenesis inhibitors: from laboratory to clinical application. Biochem Biophys Res Commun 2005;333:289-91.
39. Dhanabal M, Jeffers M, LaRochelle WJ, et al. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties. Biochem Biophys Res Commun 2005;333:308-15.
40. Hamano Y, Kalluri R. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun 2005;333:292-8.
41. Cao Y. Antiangiogenic cancer therapy. Semin Cancer Biol 2004;14:139-45.
42. Takao T, Iwaki T, Kondo J, et al. Immunohistochemistry of chondromodulin-I in the human intervertebral discs with special reference to the degenerative changes. Histochem J 2000;32:545-50.
43. Hiraki Y, Inoue H, Iyama A, et al. Identification of chondromodulin I as a novel endothelial cell growth inhibitor: purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 1997;272:32419-26.
44. Shukunami C, Oshima Y, Hiraki Y. Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun 2005; 299-307.
45. Pufe T, Petersen WJ, Miosge N, et al. Endostatin/collagen XVIII-an inhibitor of angiogenesis-is expressed in cartilage and fibrocartilage. Matrix Biol 2004;23:267-76.